Amedisys Inc (AMED)
Solvency ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 1.89 | 1.86 | 1.88 | 1.92 | 1.93 | 1.95 | 1.97 | 1.80 | 1.88 | 1.95 | 2.03 | 1.97 | 1.99 | 2.14 | 1.83 | 2.00 | 1.94 | 2.12 | 2.28 | 2.12 |
Amedisys Inc shows a consistently low debt-to-assets ratio, debt-to-capital ratio, and debt-to-equity ratio, all registered at 0.00 across various reporting periods from March 2020 to December 2024. This signifies that the company has minimal debt relative to its total assets, capital, and equity, indicating a strong solvency position and financial stability.
Furthermore, the financial leverage ratio has also been relatively stable over the years, with values ranging between 1.80 and 2.28. A downward trend is observed from March 2020 to December 2024, indicating a decreasing reliance on debt to finance its operations and investments. This suggests that Amedisys Inc is managing its leverage effectively, which is important for long-term financial health and resilience.
Coverage ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | 4.08 | 4.95 | 6.10 | 5.77 | 5.56 | 6.91 | 6.94 | 6.59 | 8.13 | 9.57 | 12.00 | 22.24 | 27.16 | 30.51 | 31.32 | 25.47 | 20.48 | 17.16 | 14.39 | 12.87 |
Amedisys Inc's interest coverage ratio has shown a generally favorable trend from March 31, 2020, to December 31, 2021, indicating the company's strong ability to cover its interest expenses with operating income. The ratio increased steadily from 12.87 on March 31, 2020, to a peak of 31.32 on June 30, 2021. However, there was a slight decline in the ratio thereafter, reaching 4.08 on December 31, 2024.
This declining trend in the interest coverage ratio after 2021 may be a cause for concern, suggesting that Amedisys Inc's ability to cover interest expenses with operating income has weakened. A decreasing trend in the ratio can indicate increasing financial risk and potential challenges in meeting debt obligations. It would be advisable for stakeholders to closely monitor Amedisys Inc's interest coverage ratio and assess the company's financial health and ability to manage debt going forward.